Glovista Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Glovista Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-222,260	Closed	-$1.68M	–	94
2018 Q4	$1.68M	Buy	222,260 +134,615	+154%	+$947K	0.47%	38
2018 Q3	$606K	Buy	+87,645	New	+$586K	0.16%	66
2016 Q3	–	Sell	-420,755	Closed	-$4.31M	–	106
2016 Q2	$4.31M	Buy	+420,755	New	+$3.86M	0.77%	23

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Glovista Investments's RDY Position: Q1 2019 in Review

Glovista Investments sold out of Dr. Reddy's Laboratories (RDY) in Q1 2019, closing a stake of 222,260 shares — an estimated $1.68M sold.

Glovista Investments first reported a position in RDY in Q2 2016 and held it in 3 quarters. The position peaked at $4.31M in Q2 2016. 143 funds tracked by Wall St. Rank hold RDY as of Q1 2019.

Glovista Investments reported no remaining Dr. Reddy's Laboratories position as of Q1 2019 after selling out during the quarter.
Glovista Investments sold 222,260 Dr. Reddy's Laboratories shares in Q1 2019, an estimated $1.68M.
Glovista Investments first reported a position in Dr. Reddy's Laboratories in Q2 2016 and held it in 3 quarters.
Glovista Investments's Dr. Reddy's Laboratories position peaked at $4.31M in Q2 2016.
143 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2019.

Based on Glovista Investments's 13F filing for Q1 2019, filed 14 May 2019.